Rio Jati Kusuma

Rio Jati Kusuma

Auto-generated profile, based on publicly available information

Rio Jati Kusuma

Department of Nutrition and Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Fahrul NurkolisFahrul Nurkolis
Fahrul Nurkolis
Nurpudji Astuti TaslimNurpudji Astuti Taslim
Nurpudji Astuti Taslim
DSDionysius Subali
Dionysius Subali
Rudy KurniawanRudy Kurniawan
Rudy Kurniawan
HHHardinsyah Hardinsyah
Hardinsyah Hardinsyah
Bonglee KimBonglee Kim
Bonglee Kim
This study evaluated the effects of an aqueous extract of Caulerpa racemosa (AEC) on cardiometabolic syndrome markers, and the modulation of the gut microbiome in mice administered a cholesterol- and fat-enriched diet (CFED). Four groups of mice received different treatments: normal diet, CFED, and CFED added with AEC extract at 65 and 130 mg/kg body weight (BW). The effective concentration (EC50) values of AEC for 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and lipase inhibition were lower than those of the controls in vitro. In the mice model, the administration of high-dose AEC showed improved lipid and blood glucose profiles and a reduction in endothelial dysfunction markers (PRMT-1 and ADMA). Furthermore, a correlation between specific gut microbiomes and biomarkers associated with cardiometabolic diseases was also observed. In vitro studies highlighted the antioxidant properties of AEC, while in vivo data demonstrated that AEC plays a role in the management of cardiometabolic syndrome via regulation of oxidative stress, inflammation, endothelial function (PRMT-1/DDAH/ADMA pathway), and gut microbiota.

3 August 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
NMNelly Mayulu
Nelly Mayulu
WGWilliam Ben Gunawan
William Ben Gunawan
Moon Nyeo ParkMoon Nyeo Park
Moon Nyeo Park
SCSanghyun Chung
Sanghyun Chung
JSJin Young Suh
Jin Young Suh
Bonglee KimBonglee Kim
Bonglee Kim
Our investigation intended to analyze the effects of sulfated polysaccharides from Caulerpa racemosa (SPCr) in attenuating obesity-induced cardiometabolic syndrome via regulating the protein arginine N-methyltransferase 1-asymmetric dimethylarginine-dimethylarginine dimethylamino-hydrolase (PRMT1-DDAH-ADMA) with the mammalian target of rapamycin-Sirtuin 1–5′ AMP-activated protein kinase (mTOR-SIRT1-AMPK) pathways and gut microbiota modulation. This is a follow-up study that used SPs from previous in vitro studies, consisting of 2,3-di-O-methyl-1,4,5-tri-O-acetylarabinitol, 2,3,4,6-tetra-O-methyl-D-mannopyranose, and type B ulvanobiuronicacid 3-sulfate. A total of forty rats were randomly divided into four treatment groups: Group A received a standard diet; Group B was provided with a diet enriched in cholesterol and fat (CFED); and Groups C and D were given the CFED along with ad libitum water, and daily oral supplementation of 65 or 130 mg/kg of body weight (BW) of SPCr, respectively. Group D showed the lowest low-density lipoprotein, triglyceride, total cholesterol, and blood glucose levels, and the highest HDL level compared to the other groups in this study. These results in the group fed high-dose SPCr demonstrated a significant effect compared to the group fed low-dose SPCr (p < 0.0001), as well as in total cholesterol and blood glucose (p < 0.05). Supplementation with SPCr was also observed to have an upregulation effect on peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha, interleukin 10, Sirtuin 1, DDAH-II, superoxide dismutase (SOD) cardio, and AMPK, which was also followed by a downregulation of PRMT-1, TNF-α, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, and mTOR. Interestingly, gut microbiota modulation was also observed; feeding the rats with a cholesterol-enriched diet shifted the gut microbiota composition toward the Firmicutes level, lowered the Bacteroidetes level, and increased the Firmicutes level. A dose of 130 mg/kg BW of SPCr is the recommended dose, and investigation still needs to be continued in clinical trials with humans to see its efficacy at an advanced level.

17 May 2021 in Current Nutrition & Food Science
Verified
Journal Article
Closed access
PDF file
RKRio J. Kusuma
Rio J. Kusuma
AEAviria Ermamilia
Aviria Ermamilia
SHSalehah N. Halimah
Salehah N. Halimah
NPNinda F. Pradani
Ninda F. Pradani
ISImroatus Sholikha
Imroatus Sholikha
Background : Enzymatic hydrolysis of fish protein using protease or fish protein hydrolysate can form bioactive peptides that have antidiabetic activity. One potential mechanism of fish protein hydrolysate is reducing blood glucose through increased endogenous glucagon like peptide (GLP)-1 production. Tempeh is soy fermented food that has protease which is potential biocatalyst in producing fish protein hydrolysate. Objective: To evaluate the antidiabetic properties of Selar (Selar crumenophthalmus) fish protein hydrolysate using tempeh protease as biocatalyst and duodenal gene expression of GLP-1. Methods: Selar fish protein isolate was digested for 8 hours at 37°C using crude tempeh protease. Diabetes mellitus was induced in rats by intraperitoneal injection of streptozotosin (65 mg/kg bw) and nicotinamide (230 mg/kg bw). Fish protein isolate and hydrolysate in dose of 300 mg/bw and 500 mg/ bw were orally administered daily for 4 weeks. Blood was drawn for fasting serum glucose and lipid profile analysis. Total RNAs were isolated from duodenum and quantitative real time PCR was performed to quantify mRNA expression of GLP-1. Data were analyzed using one way ANOVA and gene expression analysis were performed using Livak. Results and Discussion: There is a significant difference on fasting serum glucose, total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol and duodenal GLP-1 mRNA expression level between groups (p<0.05). The duodenal GLP-1 mRNA expression was the highest in rats who received hydrolyzed fish protein 500 mg/ bw. Conclusion: Hydrolysis of selar fish protein using tempeh protease has anti-diabetic properties possibly through GLP-1 production.

6 May 2023 in Food Research
Verified
Journal Article
Closed access
SBS.A. Bestari
S.A. Bestari
FFFaizah Fulyani
Faizah Fulyani
RKR.J. Kusuma
R.J. Kusuma
ELE.S. Lestari
E.S. Lestari

10 January 2021 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RKRio Kusuma
Rio Kusuma
JWJaka Widada
Jaka Widada
EHEmy Huriyati
Emy Huriyati
MJMadarina Julia
Madarina Julia
Introduction: Gut microbiota dysbiosis indicated by increased gram-negative bacteria and reduced Firmicutes-producing short chain fatty acids bacteria has been linked with impairment in glucose metabolism. Tempeh is traditional fermented soy food that can stimulate the growth of beneficial bacteria. In Indonesia, some tempeh was produced by adding acidifier that contains lactic acid bacteria. This process may impact the nutrient and anti-dysbiosis activity of tempeh. Objectives: To evaluate the impact of acidifier on nutrient and gut microbiota profile of diabetic animal model. Method: Modified tempeh was made by addition of water extract of fermented cassava. Standard and modified tempeh were subjected to proximate analysis and dietary fibre. Diabetic animals were received standard tempeh or modified tempeh diet replacing 15% and 30% of protein in the diet for 4 weeks of intervention. At the end of experiment, caecal content was collected. Short chain fatty acids and microbiota composition were analysed using 16s rDNA next generation sequencing (NGS). Result: There is significant different (p<0.05) on fat, protein, water and dietary fibre content between regular soy tempeh and modified tempeh. There is significant different (p<0.05) on serum glucose and short chain fatty acid composition among group. Diabetic animal has low ratio of Firmicutes/Bacteroidetes. Supplementation of both tempeh increased bacterial diversity, Firmicutes /Bacteroidetes ratio and short chain fatty acids producing bacteria. Conclusion: Addition of naturally occurred lactic acid bacteria from fermented cassava during tempeh processing improved both nutrient and microbiota composition in the gut of diabetes mellitus.

1 January 2022 in Current Nutrition & Food Science
Verified
Journal Article
Closed access
PDF file
RKRio Jati Kusuma
Rio Jati Kusuma
JWJaka Widada
Jaka Widada
EHEmy Huriyati
Emy Huriyati
MJMadarina Julia
Madarina Julia
Background: The role of the gut microbiota in improving glycemic control in diabetic patients is gaining attention. Tempeh is a fermented soy food from Indonesia that has antidiabetic and antidysbiotic effects. Interestingly, modification of tempeh processing by adding lactic acid bacteria has been reported to enhance the antidiabetic effect of tempeh. Aims: This study aimed to evaluate the effects of modified tempeh on serum glucose, insulin, and gut microbiota diversity of diabetic rats. Methods: Modified tempeh was developed by adding lactic acid bacteria from fermented cassava during tempeh processing. Diabetes was induced by injection of streptozotocin nicotinamide. Normal tempeh or modified tempeh was added to the diet and replaced 15% or 30% of casein. Serum glucose and insulin were analyzed before and after 30 days of intervention. At the end of the experiment, the appendix was sampled for gut microbiota analysis. Result: Modified tempeh has a significantly higher number of lactic acid bacteria (9.99 +/- 0.09 versus 7.74 +/- 0.07 log CFU, p < 0.001) compared to normal tempeh. There was a significant difference (p < 0.01) in serum glucose and insulin after treatment. Both tempeh supplements increased the diversity of the gut microbiota. Gut microbiota diversity has a strong negative correlation with delta glucose (r = -0.63, p < 0.001) and delta insulin resistance index (r = -0.54, p = 0.003). Conclusion: Modified tempeh has potential therapeutic antidiabetic activity, possibly through increased diversity of the gut microbiota.